SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

OBJ LIMITED (OBJ)

Listed on ASX ( $        )

SHARE PRICES

Former (or subsequent) names

Shareholder links

Our website ranking of OBJ: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Security Transfer Australia Pty Ltd, 770 Canning Highway Applecross WA 6153

Tel : +61 3 9628 2200
Fax : +61 8 9315 2233
RegistryWebsite RegistryEmail

Company details

Address: Level 1, 284 Oxford Street, LEEDERVILLE, WA, AUSTRALIA, 6007
Tel:  08 9443 3011 Fax: 08 9443 3866

Date first listed: 29/05/2000
Company Secretary: Mr John J Palermo
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Drug delivery technology company that specialises in transdermal drug delivery technologies
The suspension of trading in the securities of OBJ Limited will be lifted immediately following the receipt of an announcement.27/04/2017
has signed a new agreement with Procter & Gamble for the exclusive rights to another of OBJ's technology platforms. The commercialisation process of the technology will be conducted over two stages, the first focusing on generating consumer responses to the technology and the second for the product to incorporate these responses. Initial agreement will see OBJ bank upfront, standstill fees and royalties 27/04/2017
The securities of OBJ Limited will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement.24/04/2017
The suspension of trading in the securities of OBJ Limited (the "Company") will be lifted immediately, following the release by the Company of an announcement regarding results of the BodyGuard clinical trial. Security Code: OBJ23/02/2016
The company is pleased to report that The University of Queensland has completed its clinical trial examining the efficacy of OBJ's Bodyguard Kneeguard against the world's largest selling topical non-steroidal anti-inflammatory drug product with the company's primary objectives being successfully met.23/02/2016
The securities of OBJ Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement. Security Code: OBJ23/02/2016
reinstatement to quotation21/05/2004
name changed from Objectif Telecommunications Limited19/05/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    09/10/2018Steven Schapera1,100,000 $0.022$24,287
    07/08/2018Steven Schapera2,459,999 $0.029$70,880
    15/05/2018Steven Schapera349,151 $0.027$9,331
    09/05/2018Steven Schapera2,066,000 $0.027$56,525
    14/10/2014Glyn Denison-395,045 $0.106$41,795

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Steven SchaperaChairman01/08/2017
    Antonio VaranoNon Exec Director15/05/2018
    Jeff EdwardsDirector07/10/2004
    Christopher QuirkDirector19/11/2004

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Glyn DenisonDirector22/02/200620/02/2018

    Date of first appointment, title may have changed.